21Nov/13

Cadila Pharma launches new lung cancer drug – The Hindu


Newstrack India

Cadila Pharma launches new lung cancer drug
The Hindu
The new drug has been licensed and approved by the Drug Controller General of India (DCGI). Mycidac-C is meant for patients suffering from non-small cell lung cancer (NSCLC). “The drug is affordable, and is many times cheaper than what out competitors …
Ancestor of TB germ to fight lung cancerCalcutta Telegraph
Cadila Pharma launches affordable drugs for lung cancerNewstrack India
Cadila launches low-cost cancer drugTimes of India
Jagran Josh –India.Com Health
all 22 news articles »